News

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  • Reset
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

4 June 2024

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs

Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe  with Julius Clinical

28 May 2024

Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical

Avance Clinical has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS and rare diseases specialist CRO with extensive site relationships in the region.

Avance Clinical Welcomes Alex Kavros as Executive Vice President of Scientific & Regulatory Affairs

6 May 2024

Avance Clinical Welcomes Alex Kavros as Executive Vice President of Scientific & Regulatory Affairs

Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Dr Alex Kavros as the new Executive Vice President of Global Scientific & Regulatory Affairs.

Avance Clinical CEO Talks with SCRIP Intelligence about a New CRO Report and US Biotech Sector “Green Shoots”

4 March 2024

Avance Clinical CEO Talks with SCRIP Intelligence about a New CRO Report and US Biotech Sector “Green Shoots”

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings.

Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks

22 February 2024

Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings.

Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner

8 January 2024

Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner

Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program. The report found this directly affected clinical programs and budgets.

Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC

17 November 2023

Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC

Avance Clinical, the Australian and North American market-leading CRO for biotechs, has signed a strategic technology MOU with leading Korean decentralized clinical trials (DCTs) and eClinical technology company JNPMEDI Inc.

Avance Clinical Invited To Brief 45 Korean Biotechs On Their Globalready Drug Development Pathway From Korea And Australia To The Us

19 October 2023

Avance Clinical Invited To Brief 45 Korean Biotechs On Their Globalready Drug Development Pathway From Korea And Australia To The Us

Avance Clinical was asked to present their GlobalReady drug development solution to more than 45 Korean biotechs and pharmaceutical companies in Seoul, Korea as part of a special symposium at KoNECT Korea Conference.

Biotech CRO Leader, Avance Clinical, Backs California Life Sciences Entrepreneurship Program With Gold Sponsorship

27 September 2023

Biotech CRO Leader, Avance Clinical, Backs California Life Sciences Entrepreneurship Program With Gold Sponsorship

Avance Clinical is proud to announce its gold sponsorship of California Life Sciences (CLS) Innovation and Entrepreneurship programming.

Avance Clinical Appoints US-Based Executives – SVP Scientific And Regulatory Affairs, And Director Business Development

21 September 2023

Avance Clinical Appoints US-Based Executives – SVP Scientific And Regulatory Affairs, And Director Business Development

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, announces two key appointments in the US to support its continued global growth.

CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan

18 September 2023

CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan

Avance Clinical is proud to announce that Chief Executive Officer Yvonne Lungershausen has been nominated for Executive of the Year in the 2023 Citeline Pharma Intelligence Awards in Japan.

Join Avance Clinical In Seoul At KoNECT Korea 2023

14 September 2023

Join Avance Clinical In Seoul At KoNECT Korea 2023

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with South Korean biotech companies.

Proven industry
experience & expertise

500+

Studies in the past 5 years

330+

Experienced team members

18k+

Participants past 5 years

30

Years of CRO experience